Close
Help
Need Help?
Search



Perspectives in Medicinal Chemistry Added to Gale Academic OneFile

Posted Mon, Jun, 18,2012

Libertas is pleased to announce that Perspectives in Medicinal Chemistry has now been added to Gale's Academic OneFile database.

GALE operates more than 600 databases, including the popular InfoTrac and General Reference series. The Michigan based company is popular with authors working in the USA, so inclusion of Perspectives in Medicinal Chemistry in GALE's Academic OneFile will increase article visibility in North America.

In addition to it's American popularity, GALE has offices in Europe, the Middle East, Africa, Asia, Australia, New Zealand and Latin America. Libertas' partnership with GALE will provide a further strengthening of the already substantial visibility achieved by Perspectives in Medicinal Chemistry, and make articles published in the journal accessible to an even larger audience around the world.

To see where else the journal is indexed, visit the Perspectives in Medicinal Chemistry homepage

share on

Posted in: Indexes, Databases, and Directories

News Categories

RECENT ENTRIES

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
testimonial_image
I would like to extend my gratitude for creating the next generation of a scientific journal -- the science journal of tomorrow. The entire process bespoke of exceptional efficiency, celerity, professionalism, competency, and service.
Dr Jason B. Nikas (Medical School University of Minnesota, Minneapolis, MN, USA)
More Testimonials

Quick Links

Follow Us We make it easy to find new research papers.
Email AlertsRSS Feeds
FacebookGoogle+Twitter
PinterestTumblrYouTube

SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results